Turn Therapeutics Inc. (TTRX) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4

Key dataNov 4, 2026

Open$9.77

From 52W high−36.11%

Volume93916.00

Market cap$299.22M

P/E (TTM)—

P/S (TTM)—

Div yield—

Key dataNov 4, 2026

Open

$9.77

From 52W high

−36.11%

Volume

93916.00

Market cap

$299.22M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−70.8x

P/E (TTM)

—

RSI (14)

40.2

MomentumView details →

1D Return

+3.05%

YTD Return

+148.22%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−70.8x

EV/Sales

—

P/S (TTM)

—

P/B (TTM)

435.6x

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

−1229.58%

ROA (TTM)

−49.80%

Asset Turnover

0.00x

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

—

EPS CAGR 3Y

−76.92%

EBITDA YoY

—

MomentumView details →

1D Return

+3.05%

YTD Return

+148.22%

1Y Return

+126.39%

RSI (14)

40.2

vs 50D SMA

−16.60%

vs 200D SMA

+38.20%

Capital & dividendView details →

Debt/Equity

8.91x

Current Ratio

1.19x

Quick Ratio

1.19x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−$0.20

EPS Surprise

−900.00%

Beats (12Q)

0/12

Next Q EPS Est

−$0.12

Avg Surprise (4Q)

−342.16%

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

0.00

Net Income (TTM)

−8.45M

Op. CF (TTM)

−4.32M

Next earningsNov 12, 2026 →

Latest newsMore news →

Turn Therapeutics announced new peer-reviewed research showing its product GX-03 selectively reduces key drivers of skin inflammation and itch.76d ago

Turn Therapeutics Inc. completed the full cashless exercise of a warrant to purchase its common stock, issuing 579,664 shares of common stock to GEM Global Yield LLC SCS and GEM Yield Bahamas Limited at an exercise price of $5.03 per share, relying on the Section 4(a)(2) exemption for accredited investors.79d ago

Similar companies

Ocugen, Inc.OCGN Century Therapeutics, Inc.IPSC ARS Pharmaceuticals, Inc.SPRY Vogenx Inc.VOGX Nautilus Biotechnology, Inc.NAUT Arcturus Therapeutics Holdings Inc.ARCT Find similar companies →

Latest newsMore news →

Turn Therapeutics announced new peer-reviewed research showing its product GX-03 selectively reduces key drivers of skin inflammation and itch.76d ago Turn Therapeutics Inc. completed the full cashless exercise of a warrant to purchase its common stock, issuing 579,664 shares of common stock to GEM Global Yield LLC SCS and GEM Yield Bahamas Limited at an exercise price of $5.03 per share, relying on the Section 4(a)(2) exemption for accredited investors.79d ago